Seventy-five percent of the patients (18 out of 24) with subsequent myeloid malignancies had CHIP mutations, which is similar to the previous case-control studies where 62-71% of the t-MN cases had CHIP mutations 5, 6. The gene discussed is STUB1; the disease is myeloid neoplasm.